Kenneth M. Ferguson

Insider Reports History

Location
2125 1 St Avenue #2902, Seattle, WA
Signature
/s/ Kenneth M. Ferguson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth M. Ferguson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Director Common Stock 45K $149K $3.32 Jun 30, 2023 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 42.4K Jun 30, 2023 Direct

Insider Reports Filed by Kenneth M. Ferguson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 2 $0 4 Jul 3, 2023 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 14, 2022 2 $0 4/A Jun 17, 2022 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 14, 2022 0 $0 3 Jun 16, 2022 Director